glp-1 fda shortage Proposes Ban on Bulk Compounding for Semaglutide, Tirzepatide, and Liraglutide FDA Ends Semaglutide Shortage Listing,

For the first time in years a person can make a food choice from a calm place rather than a compulsive one

Weight loss can be a difficult journey for many people, especially when they are on the border of obesity

Wegovy sales rose 18% year-over-year in Q3, down from 67% growth in Q2, while Ozempic slowed to 3% growth from 15% in the prior quarter

Improved liver enzymes: ALT and AST (markers of liver inflammation) typically decrease with treatment

Many private insurers will approve these drugs when prescribed for diabetes management but exclude them when used primarily for weight loss

Modern GLP-1 medications are designed to mimic this exact hormone, but with a longer-lasting effect